Zacks Investment Research
14 Oct 2026, 15:46 UTC · 1h ago
Is BWXT a Buy as Nuclear Growth Meets Execution and Valuation Risk?
Impact · against what's priced in
The article provides no new catalysts for BWXT, as the $1.4 billion in naval contracts and the uranium-enrichment facility progress were already factored into the growth narrative. With the stock trading near its five-year median multiple, the current valuation leaves little room for error regarding second-half execution.
- BWXT+0.00
No priced-in read yet
- In context
The mentioned $1.4 billion in naval contracts and the $1.5 billion NNSA contract for uranium enrichment are previously known milestones that align with current guidance and valuation.
Read from the article alone
Top 1 mover · tap to explore
